K-numberK243052
Device nameGlean Urodynamics System Male Delivery System (GUS-1000-M); Glean Urodynamics System Female Delivery System (GUS-1000-F); Glean Urodynamics System Uroflowmeter (UFM-1000 (Uroflowmeter))
ApplicantBright Uro, Inc.
Product codeEXQ
Device classClass II
Decision dateMar 24, 2025
DecisionSubstantially Equivalent
Regulation876.1620
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Glean Urodynamics System is a single-channel urodynamic analyzer for diagnosing lower urinary tract dysfunction in adult patients. It measures bladder pressure and flow characteristics through a minimally invasive electronic sensor inserted transurethrally, enabling standard urodynamic tests (uroflow, cystometrogram, urethral pressure profile, and micturition studies) to diagnose incontinence, urinary retention, and neurological micturition disorders.

Technological characteristics

The subject device uses an implantable electronic pressure sensor (silicone housing, <5.35mm diameter) housed in the bladder with integrated wireless data transmission and a removal string, compared to the predicate's external catheter (8 Fr, TPU-PVC material) connected to external sensors. Both measure 0-320 cm H2O at 20 Hz sampling rate, support ambulatory monitoring with single-use designs, and integrate uroflowmetry; the subject device omits integrated EMG capability present in the predicate.

Test standards cited

ISO 10993-1:2018 (biocompatibility), IEC 60601-1:2020 (electrical safety), IEC 60601-1-2:2020 (electromagnetic compatibility), ISO 11135:2014 (ethylene oxide sterilization), FDA guidance on software verification/validation, cybersecurity risk management, and human factors engineering. A GLP chronic animal safety study on sheep was also conducted.

Substantial equivalence argument

Although the subject device employs different technological characteristics (implantable sensor versus external catheter), both devices share identical intended use for standard urodynamic testing in adults with lower urinary tract dysfunction. The differences in design do not raise different safety or effectiveness questions because the subject device demonstrated comparable diagnostic accuracy, similar adverse event profiles, and successful pressure measurement in a 32-patient clinical study. The reference device (Dantec Duet) supported use of electronic pressure sensors, and extensive non-clinical testing (biocompatibility, electrical safety, sterilization) and clinical performance data demonstrated the subject device's safety and efficacy within the same clinical application.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →